Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Blood doping and cardiovascular consequences].

Jean Gauthier1

  • 1Fédération Internationale de Football (FIFA) Club des Cardiologues du Sport, Arles.

Presse Medicale (Paris, France : 1983)
|February 13, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LightSpot<sup>®</sup>-FL-1 Fluorescent Probe: An Innovative Tool for Cancer Drug Resistance Analysis by Direct Detection and Quantification of the P-glycoprotein (P-gp) on Monolayer Culture and Spheroid Triple Negative Breast Cancer Models.

Cancers·2021
Same author

The New Serum-Free OptiPASS<sup>®</sup> Medium in Cold and Oxygen-Free Conditions: An Innovative Conservation Method for the Preservation of MDA-MB-231 Triple Negative Breast Cancer Spheroids.

Cancers·2021
Same author

Epidemiological characteristics and therapeutic management of patients with chronic heart failure who use smartphones: Potential impact of a dedicated smartphone application (report from the OFICSel study).

Archives of cardiovascular diseases·2020
Same author

The New Synthetic Serum-Free Medium OptiPASS Promotes High Proliferation and Drug Efficacy Prediction on Spheroids from MDA-MB-231 and SUM1315 Triple-Negative Breast Cancer Cell Lines.

Journal of clinical medicine·2019
Same author

Alterations in echocardiographic and electrocardiographic features in Japanese professional soccer players: comparison to African-Caucasian ethnicities.

European journal of preventive cardiology·2012
Same author

Binding site characterization and resistance to a class of non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase.

The Journal of biological chemistry·2005
Same journal

Predictive analytics and risk stratification models in internal medicine: from risk scores to real-time machine learning.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in skin disease therapeutics: from drug discovery to personalized treatment pathways.

Presse medicale (Paris, France : 1983)·2026
Same journal

AI in clinical diagnostics in dermatology: applications, validation, and real-world use cases.

Presse medicale (Paris, France : 1983)·2026
Same journal

Artificial Intelligence in medical research and publishing: progress, risks, and future perspectives.

Presse medicale (Paris, France : 1983)·2026
Same journal

Ethical, legal, and regulatory challenges in AI-based healthcare tools.

Presse medicale (Paris, France : 1983)·2026
Same journal

Decision-making for clinicians.

Presse medicale (Paris, France : 1983)·2026
See all related articles

Blood doping aims to enhance athletic performance by increasing oxygen delivery to muscles. However, methods like blood transfusions and erythropoietin use pose serious health risks, including thrombosis.

Area of Science:

  • Sports Medicine
  • Hematology
  • Physiology

Background:

  • Blood doping aims to artificially enhance oxygen-carrying capacity.
  • This practice is prevalent in competitive sports to improve endurance.

Purpose of the Study:

  • To outline the motivations behind blood doping.
  • To detail the methods used in blood doping.
  • To describe the adverse health consequences of blood doping.

Main Methods:

  • Review of blood doping techniques, including autologous blood transfusion.
  • Identification of banned substances such as erythropoietin (EPO) and blood substitutes.
  • Analysis of physiological risks associated with doping.

Main Results:

Related Experiment Videos

  • Blood doping enhances oxygen supply to muscles, improving athletic performance.
  • Methods include blood transfusions, EPO, and synthetic oxygen carriers.
  • Key risk is hyperviscosity syndrome, leading to thrombosis and reduced cardiac output.

Conclusions:

  • Physicians must be aware of doping complications in clinical practice.
  • Knowledge of prohibited substances is crucial for medical professionals to prevent prescription errors.